التفاصيل البيبلوغرافية
| العنوان: |
Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemotherapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study. |
| المؤلفون: |
Van Der Heijden, Michiel Simon, Powles, Thomas, Gupta, Shilpa, Bedke, Jens, Kikuchi, Eiji, De Wit, Ronald, Galsky, Matt D., Duran, Ignacio, Necchi, Andrea, Retz, Margitta, Yu, Evan Y., Hoffman-Censits, Jean H., Iyer, Gopa, Park, Se Hoon, Su, Wen-Pin, Parmar, Hema, Guan, Xuesong, Gorla, Seema Rao, Homet Moreno, Blanca, Valderrama, Begoña Pérez |
| المصدر: |
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pLBA530-LBA530, 6p |
| قاعدة البيانات: |
Supplemental Index |
